Board director and strategic advisor to PE-backed companies at the intersection of AI, digital health, and precision medicine.
Hands-on advisory built on operating experience — not theory.
Independent director and board observer roles for PE-backed AI health companies. Governance, strategy, and accountability from someone who has sat in the CEO chair.
Learn More →Go-to-market strategy, fundraising roadmap, regulatory pathway, executive coaching. Retainer-based engagements calibrated to where your company is in the journey.
Learn More →$150M+ raised across multiple companies. From Series A positioning to late-stage structured rounds — narrative, materials, process, and introductions.
Learn More →Companies built from the ground up.
Founded with the University of Chicago to commercialize early AI technology developed at Argonne National Lab. This venture capital backed start-up built the first "Internet of Things" solution to monitor the health of mission critical industrial equipment like jet engines, nuclear power plants and chemical processing plants. After expanding globally, the company was acquired by GE.
Spinning out of SmartSignal with an IP license of SmartSignal's 100+ patents for the field of Biological systems, built the first AI-enabled biomarker company — obtaining the first AI-based Digital Twin cleared by the FDA. The solution was ISO 13485 certified and served the Clinical Trial and Clinical Care markets with 5 AI-based, FDA cleared biomarkers.
Stealth start-up using AI and wearables to address the immuno-oncology industry's need for safety monitoring, both in Clinical Trials and Clinical Care.
Gary brings operational credibility — not just governance theory. He's raised the capital, navigated FDA, and delivered the exit.
Explore Board Advisory →Whether you're raising your Series A, preparing for FDA, or figuring out go-to-market — Gary has navigated it.
Schedule a Conversation →